Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia.
暂无分享,去创建一个
E. Siemers | R. Dean | A. Schwarz | P. Yu | Y. Qi | G. Sethuraman | J. Tauscher | B. Willis | F. Martényi | S. Hall